Chanda Sanjay (CIK 1571820) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-23). Recent activity: Buy ANTX (38,000 shares), Sell ANTX (3,295 shares), Sell ANTX (5,956 shares), Buy ANTX (50,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-23 | AN2 Therapeutics, Inc. (ANTX) | Chief Development Officer | Buy | 38,000 | $0 |
| 2026-01-07 | AN2 Therapeutics, Inc. (ANTX) | Chief Development Officer | Sell | 3,295 | $3,295 |
| 2026-01-07 | AN2 Therapeutics, Inc. (ANTX) | Chief Development Officer | Sell | 5,956 | $6,016 |
| 2025-02-28 | AN2 Therapeutics, Inc. (ANTX) | Chief Development Officer | Buy | 50,250 | $0 |
Source: SEC Form 4 filings · as of 2026-02-23